Weight loss drug Wegovy and generic Mounjaro.

According to trial data released by the pharmaceutical company Eli Lilly,

[{"selector":"#anim-7dfabd6e-1631-47fd-ae62-40509679e631","keyframes":{"opacity":[0,1]},"delay":100,"duration":2000,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-c51a1bb7-acf3-47af-a86e-c36ba3d7e8e5","keyframes":{"transform":["translate3d(0px, 222.09449%, 0)","translate3d(0px, 0px, 0)"]},"delay":100,"duration":2000,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}]

the active ingredient in the diabetic drug Mounjaro, tirzepatide, can assist patients in losing close to 16% of their body weight.1

[{"selector":"#anim-3cda3899-af5e-4cee-8137-fa7ff42b1daa","keyframes":{"opacity":[0,1]},"delay":100,"duration":2000,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-c50b7479-289e-4534-bf30-87e35f32aa06","keyframes":{"transform":["translate3d(0px, 144.37712%, 0)","translate3d(0px, 0px, 0)"]},"delay":100,"duration":2000,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}]

According to Lilly, the weight loss recorded in this trial was larger than that seen with other drugs for type 2 diabetes and obesity.

[{"selector":"#anim-9c932b7f-66a8-42f0-b330-6ad9fabe11d2","keyframes":{"opacity":[0,1]},"delay":100,"duration":2000,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-0fbe8278-1733-404c-958a-3a7e9874921b","keyframes":{"transform":["translate3d(0px, 152.25591%, 0)","translate3d(0px, 0px, 0)"]},"delay":100,"duration":2000,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}]

Although the drug is being used off-label, the company said it will ask the Food and Drug ...

[{"selector":"#anim-c2bf54c5-eeec-4826-99f7-2a8fc5ff74b6","keyframes":{"opacity":[0,1]},"delay":100,"duration":2000,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-60bbd393-d172-47fc-874d-27ffd3ef15ea","keyframes":{"transform":["translate3d(0px, 160.77446%, 0)","translate3d(0px, 0px, 0)"]},"delay":100,"duration":2000,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}]

...Administration (FDA) to approve an indication for weight management.

[{"selector":"#anim-ca6fe084-cd55-47bb-b29d-5fa8b035f5f2","keyframes":{"opacity":[0,1]},"delay":100,"duration":2000,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-44cc73c0-8b03-4239-9d22-8432e62f3a53","keyframes":{"transform":["translate3d(0px, 197.16546%, 0)","translate3d(0px, 0px, 0)"]},"delay":100,"duration":2000,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}]

"It's wonderful that we now have another drug that promotes weight loss while also enhancing glycemic control.

[{"selector":"#anim-010d8893-80fd-4b88-a8a4-3e15f3527c0c","keyframes":{"opacity":[0,1]},"delay":100,"duration":2000,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-6e6c4a11-1999-4689-9440-c372a275e10f","keyframes":{"transform":["translate3d(0px, 147.40742%, 0)","translate3d(0px, 0px, 0)"]},"delay":100,"duration":2000,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}]

David Lau, MD, PhD, adjunct professor in the departments of medicine, biochemistry and molecular biology,

[{"selector":"#anim-22573b54-6659-4ad8-be51-db71015e533b","keyframes":{"opacity":[0,1]},"delay":100,"duration":2000,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-e6f2dfa1-9388-4973-8524-f16d4c616358","keyframes":{"transform":["translate3d(0px, 148.61952%, 0)","translate3d(0px, 0px, 0)"]},"delay":100,"duration":2000,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}]

and kinesiology at the University of Calgary, told Verywell that if [tirzepatide] is approved for the management of obesity,

[{"selector":"#anim-2b37e98b-c1e8-4530-b201-460fee874aaf","keyframes":{"opacity":[0,1]},"delay":100,"duration":2000,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-756f61fc-a3fb-444c-bc85-6f329555150d","keyframes":{"transform":["translate3d(0px, 150.36663%, 0)","translate3d(0px, 0px, 0)"]},"delay":100,"duration":2000,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}]

[{"selector":"#anim-47bc2f55-06ce-4928-a979-51dd94ba51bf","keyframes":{"opacity":[0,1]},"delay":100,"duration":2000,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-613d65d7-f4c2-47f0-82f4-2f7e8728e8df","keyframes":{"transform":["translate3d(0px, 405.40933%, 0)","translate3d(0px, 0px, 0)"]},"delay":100,"duration":2000,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-8101ab4a-b8d3-477b-b713-853e76586e38","keyframes":{"opacity":[0,1]},"delay":100,"duration":2000,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-78960922-cb08-488a-a776-b8f501e8cde9","keyframes":{"transform":["translate3d(0px, 186.22225%, 0)","translate3d(0px, 0px, 0)"]},"delay":100,"duration":2000,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] THANK YOU FOR VISITING TRENDING STORIES Learn more